4//SEC Filing
REVA Medical, Inc. 4
Accession 0001209191-17-022392
CIK 0001496268operating
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:48 PM ET
Size
7.2 KB
Accession
0001209191-17-022392
Insider Transaction Report
Form 4
REVA Medical, Inc.RVA:AX
Anderson Jeffrey A.
VP, Clinical & Regulatory
Transactions
- Award
Stock Option (right to buy)
2017-03-20+41,000→ 41,000 totalExercise: $7.72Exp: 2027-03-20→ Common Stock (41,000 underlying) - Award
Common Stock
2017-03-20+20,500→ 21,000 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis. These restricted stock units shall vest annually on the anniversary date of the grant (March 20), with the first vesting occurring on March 20, 2018, at the rate of 33.3% annually, until fully vested.
- [F2]25% of the shares vest on March 20, 2018, with the remaining shares vesting at 2.08333% per month thereafter until fully vested.
Documents
Issuer
REVA Medical, Inc.
CIK 0001496268
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001496268
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 5:48 PM ET
- Size
- 7.2 KB